16,500 Shares in The Pennant Group, Inc. (NASDAQ:PNTG) Bought by Tidemark LLC

Tidemark LLC purchased a new stake in The Pennant Group, Inc. (NASDAQ:PNTG) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 16,500 shares of the company’s stock, valued at approximately $230,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Paradigm Capital Management Inc. NY grew its holdings in The Pennant Group by 79.1% during the 3rd quarter. Paradigm Capital Management Inc. NY now owns 1,196,500 shares of the company’s stock worth $13,317,000 after acquiring an additional 528,612 shares during the period. Kent Lake Capital LLC grew its stake in The Pennant Group by 34.6% during the third quarter. Kent Lake Capital LLC now owns 583,631 shares of the company’s stock worth $6,496,000 after purchasing an additional 150,187 shares during the period. Trexquant Investment LP grew its stake in The Pennant Group by 186.0% during the fourth quarter. Trexquant Investment LP now owns 89,656 shares of the company’s stock worth $1,248,000 after purchasing an additional 58,310 shares during the period. First Eagle Investment Management LLC increased its holdings in The Pennant Group by 16.7% in the third quarter. First Eagle Investment Management LLC now owns 397,900 shares of the company’s stock worth $4,429,000 after purchasing an additional 56,893 shares in the last quarter. Finally, GSA Capital Partners LLP lifted its stake in The Pennant Group by 71.2% in the third quarter. GSA Capital Partners LLP now owns 118,101 shares of the company’s stock valued at $1,314,000 after buying an additional 49,114 shares during the period. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Stock Down 1.7 %

Shares of NASDAQ:PNTG traded down $0.40 during midday trading on Thursday, hitting $22.73. 41,300 shares of the company’s stock were exchanged, compared to its average volume of 154,841. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.16 and a quick ratio of 1.16. The Pennant Group, Inc. has a 12 month low of $10.31 and a 12 month high of $24.06. The company has a market cap of $683.04 million, a PE ratio of 42.70, a price-to-earnings-growth ratio of 2.48 and a beta of 2.01. The stock has a 50 day moving average price of $20.80 and a 200-day moving average price of $17.05.

The Pennant Group (NASDAQ:PNTG) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.01). The Pennant Group had a net margin of 2.86% and a return on equity of 13.42%. The business had revenue of $145.95 million during the quarter, compared to analysts’ expectations of $136.79 million. During the same quarter in the prior year, the firm posted $0.15 earnings per share. On average, sell-side analysts anticipate that The Pennant Group, Inc. will post 0.73 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Oppenheimer lifted their price objective on shares of The Pennant Group from $18.00 to $22.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. Stephens reaffirmed an “overweight” rating and issued a $23.00 price target on shares of The Pennant Group in a research note on Tuesday, May 7th. Truist Financial increased their price objective on shares of The Pennant Group from $22.00 to $25.00 and gave the stock a “hold” rating in a research report on Wednesday, May 15th. Finally, Royal Bank of Canada upped their price target on The Pennant Group from $21.00 to $26.00 and gave the stock an “outperform” rating in a research note on Thursday, May 9th.

The Pennant Group Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.